Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have developed […]
Associate Professor Fumio Tanaka and his research group at the Osaka Metropolitan University Graduate School of Medicine recorded […]
Unrelenting pressure caused by strikes, flu and COVID-19 may be keeping NHS in vicious cycle
Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation chemotherapy combined with […]
A team of mathematicians and pharmaceutical scientists collaborated to identify the major cause of the low accuracy of […]
Updated Date: Tue, 10 Jan 2023 00:00:00 EST
Biosimilar gains MHRA marketing authorisation for use throughout Britain
Industry-first cancer screening technology boosted by biomedical grant funding
For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of […]